GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Nephros Inc (FRA:NPJP) » Definitions » Research & Development

Nephros (FRA:NPJP) Research & Development : €0.79 Mil (TTM As of Sep. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Nephros Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Nephros's Research & Development for the three months ended in Sep. 2024 was €0.17 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Sep. 2024 was €0.79 Mil.

Nephros Research & Development Historical Data

The historical data trend for Nephros's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nephros Research & Development Chart

Nephros Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.78 2.27 1.33 1.19 0.80

Nephros Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.19 0.19 0.20 0.24 0.17

Nephros Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.79 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nephros  (FRA:NPJP) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Nephros Research & Development Related Terms

Thank you for viewing the detailed overview of Nephros's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Nephros Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Nephros Inc (FRA:NPJP) » Definitions » Research & Development
Comparable Companies
EKSO UEEC MBOT LUCY IMTH MHUA CBSC RVP BNGO POAI ISRG XPAR:EL BDX TSE:7741 XSWX:ALC RMD TSE:4543 OCSE:COLO B WST XSWX:STMN
Traded in Other Exchanges
NEPH:USA
Address
380 Lackawanna Place, South Orange, NJ, USA, 07079
Website
https://www.nephros.com
Nephros Inc is a commercial-stage company that develops and sells high-performance water solutions to the medical and commercial markets. In medical markets, it sells water filtration products and waterborne pathogen detection products. In commercial markets, the company manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. The company's subsidiary is engaged in the development of its second-generation hemodiafiltration system and other products focused on improving therapies for patients with renal disease.

Nephros Headlines

No Headlines